: Developing gene therapies for rare neurological disorders like Rett syndrome. It carries a unanimous Strong Buy from analysts, with significant upside potential tied to upcoming clinical updates.
The following table summarizes the monthly performance of some top-performing high-risk stocks as of April 14, 2026: Monthly Performance CHGG PDSB PDS Biotechnology HURA TuHURA Biosciences CURV Torrid Holdings Data sourced from NerdWallet . Risks to Consider junk stocks to buy
: Has recently surged over +16%, appearing on several "promising" lists for its recovery trajectory. : Developing gene therapies for rare neurological disorders
Some larger "junk" names are companies that have seen massive price crashes but are showing signs of life as of late April 2026: Risks to Consider : Has recently surged over
: A Bitcoin mining company gaining attention due to operational expansion and energy efficiency. It is often cited as a top pick for investors seeking high-volatility cryptocurrency exposure.